Petros Grivas, MD, PhD, is a board certified oncologist at Seattle Cancer Care Alliance, a director at the University of Washington School of Medicine's genitourinary cancers program, and an associate professor of oncology.
Considered an international expert in genitourinary cancer, Dr. Grivas played an important role in clinical trials that led to the FDA approval of new drugs for bladder/urothelial cancer. He lectures internationally, pursues community outreach, and leads studies, and publishes novel research. He is dedicated to efficient, personalized, outstanding patient care and optima patient-physician relationships.